Annual Current Assets
$21.59 B
-$1.92 B-8.18%
December 31, 2023
Summary
- As of February 7, 2025, BNTX annual total current assets is $21.59 billion, with the most recent change of -$1.92 billion (-8.18%) on December 31, 2023.
- During the last 3 years, BNTX annual current assets has risen by +$19.54 billion (+952.84%).
- BNTX annual current assets is now -8.18% below its all-time high of $23.51 billion, reached on December 31, 2022.
Performance
BNTX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$20.65 B
+$1.05 B+5.36%
September 1, 2024
Summary
- As of February 7, 2025, BNTX quarterly total current assets is $20.65 billion, with the most recent change of +$1.05 billion (+5.36%) on September 1, 2024.
- Over the past year, BNTX quarterly current assets has dropped by -$938.24 million (-4.35%).
- BNTX quarterly current assets is now -12.17% below its all-time high of $23.51 billion, reached on December 31, 2022.
Performance
BNTX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
BNTX Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -8.2% | -4.3% |
3 y3 years | +952.8% | -5.0% |
5 y5 years | +4103.1% | +3664.5% |
BNTX Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -8.2% | +26.5% | -12.2% | +21.0% |
5 y | 5-year | -8.2% | +3340.1% | -12.2% | +3698.3% |
alltime | all time | -8.2% | +9387.8% | -12.2% | +3920.4% |
BioNTech SE Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $20.65 B(+5.4%) |
Jun 2024 | - | $19.60 B(-0.7%) |
Mar 2024 | - | $19.73 B(-8.6%) |
Dec 2023 | $3.85 B(+164.2%) | $21.59 B(+8.8%) |
Sep 2023 | - | $19.85 B(-5.0%) |
Jun 2023 | - | $20.88 B(-4.7%) |
Mar 2023 | - | $21.90 B(-6.8%) |
Dec 2022 | $1.46 B(+69.5%) | $23.51 B(+12.5%) |
Sep 2022 | - | $20.90 B(-1.0%) |
Jun 2022 | - | $21.11 B(-2.8%) |
Mar 2022 | - | $21.73 B(+27.3%) |
Dec 2021 | $858.79 M | $17.07 B(+8.6%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $15.72 B(+56.5%) |
Jun 2021 | - | $10.04 B(+142.3%) |
Mar 2021 | - | $4.15 B(+102.2%) |
Dec 2020 | $801.56 M(+201.3%) | $2.05 B(+59.9%) |
Sep 2020 | - | $1.28 B(+83.5%) |
Jun 2020 | - | $698.55 M(+28.5%) |
Mar 2020 | - | $543.59 M(-13.4%) |
Dec 2019 | $266.04 M(+14.0%) | $627.46 M(+14.4%) |
Sep 2019 | - | $548.47 M(-4.4%) |
Jun 2019 | - | $573.41 M(+11.7%) |
Dec 2018 | $233.38 M(+5.1%) | $513.57 M |
Dec 2017 | $222.04 M(+192.4%) | - |
Dec 2016 | $75.94 M | - |
FAQ
- What is BioNTech SE annual total current assets?
- What is the all time high annual current assets for BioNTech SE?
- What is BioNTech SE annual current assets year-on-year change?
- What is BioNTech SE quarterly total current assets?
- What is the all time high quarterly current assets for BioNTech SE?
- What is BioNTech SE quarterly current assets year-on-year change?
What is BioNTech SE annual total current assets?
The current annual current assets of BNTX is $21.59 B
What is the all time high annual current assets for BioNTech SE?
BioNTech SE all-time high annual total current assets is $23.51 B
What is BioNTech SE annual current assets year-on-year change?
Over the past year, BNTX annual total current assets has changed by -$1.92 B (-8.18%)
What is BioNTech SE quarterly total current assets?
The current quarterly current assets of BNTX is $20.65 B
What is the all time high quarterly current assets for BioNTech SE?
BioNTech SE all-time high quarterly total current assets is $23.51 B
What is BioNTech SE quarterly current assets year-on-year change?
Over the past year, BNTX quarterly total current assets has changed by -$938.24 M (-4.35%)